|
Medications Development Centers (MDC) |
|
|
|
|
The Medications Development Centers (MDC) are a group of seven research center grants awarded around the country focusing on testing new or marketed medications for substance abuse treatment.
Mission:
To support the clinical development of new medications, or new indications for marketed medications for substance abuse treatment or nicotine dependence. Obtain abstracts of grants and contact information.
Locations:
| Cocaine Pharmacotherapy Targeting Dopamine & GABA
Baylor College of Medicine
Dept. of Psychiatry & Behavioral Sciences
1 Baylor Plaza
Houston, TX 77030-3498
Thomas R. Kosten, M.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | Center for Research Improving Treatment of Drug Abuse
University of Pennsylvania School of Medicine
Dept. of Psychiatry
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104
Charles P. O’Brien, M.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | Innovative Approaches for Cocaine Pharmacotherapy
University of Pennsylvania School of Medicine
Dept. of Psychiatry
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104
Helen M. Pettinati, Ph.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | Methamphetamine Pharmacotherapy Development Center
California Pacific Medical Center Research Institute
San Francisco, CA 94107
John Mendelson, M.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | Novel Medications Approaches for Substance Abuse
New York State Psychiatric Institute
1051 Riverside Drive
New York, NY 10032
Herbert D. Kleber, M.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | Substance Abuse Research — Medications Development Center
University of Texas Health Sciences Center
Box 20036
Houston, TX 77225
F. Gerard Moeller, M.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | UCLA Medication Development Unit for Stimulant Abuse
University of California, Los Angeles
David Geffen School of Medicine
Dept. of Family Medicine
10880 Wilshire Boulevard, Suite 1800
Los Angeles, CA 90095-9087
Steven Shoptaw, Ph.D.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| | |
|
